Compare AUTL & REAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AUTL | REAX |
|---|---|---|
| Founded | 2014 | 2018 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 388.6M | 386.3M |
| IPO Year | 2025 | 2021 |
| Metric | AUTL | REAX |
|---|---|---|
| Price | $1.53 | $1.76 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | ★ $8.50 | $5.49 |
| AVG Volume (30 Days) | 1.2M | ★ 3.2M |
| Earning Date | 05-14-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $10,120,000.00 | N/A |
| Revenue This Year | $80.32 | $23.04 |
| Revenue Next Year | $53.96 | $15.98 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 496.00 | N/A |
| 52 Week Low | $1.18 | $1.55 |
| 52 Week High | $2.70 | $5.41 |
| Indicator | AUTL | REAX |
|---|---|---|
| Relative Strength Index (RSI) | 46.27 | 47.31 |
| Support Level | $1.41 | $1.59 |
| Resistance Level | $1.73 | $1.86 |
| Average True Range (ATR) | 0.12 | 0.10 |
| MACD | -0.02 | 0.03 |
| Stochastic Oscillator | 29.54 | 64.52 |
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8. Company's T cell programming technologies tailors therapies to address the specific disease targeting and introduce new programming modules into a patient's T cells to give those T cells improved properties to recognize target cells and overcome fundamental disease defense mechanisms.
The Real Brokerage Inc is a technology-powered real estate brokerage firm located in the United States and Canada. It has developed a proprietary transaction management and brokerage operations software called reZEN, which powers nearly all of its brokerage operations, enabling efficiency, automation, and flexibility by incorporating end-to-end transaction management, automated compliance and brokerage oversight, integrated payments and financial services, Leo CoPilot, and open API for customization. In addition, the company also offers mortgage brokering and title services. The company's operating segments are North American Brokerage, which derives key revenue, One Real Title, One Real Mortgage, and Real Wallet. Geographically, it derives key revenue from the United States.